EUVIMEDEUVIMED entdecken
Crossref

Silibinin alleviates lung fibrosis by targeting Annexin A6 to suppress endoplasmic reticulum stress and oxidative stress

Ruijuan Guan, Yingli Zhang, Zhengyang Wang, Danxia Huang, Yakun Bai, Meifang Deng, Kailin Li, Xiao Hu, Fei Huang, Ying Dai, Fang Tian, Zhiyuan Xu und 3 weitere

Phytomedicine · 2026

DOI: 10.1016/j.phymed.2026.158041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2026. Verfasst von Ruijuan Guan und 14 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, th…. Hauptthemen laut MEDLINE: Oxidative Stress, Silybin, Pulmonary Fibrosis, Endoplasmic Reticulum Stress. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: National Natural Science Foundation of China, State Key Laboratory of Respiratory Disease, Natural Science Foundation of Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Endoplasmic reticulum (ER) stress and oxidative stress are closely linked in driving the TGF-β1-mediated proliferation and myofibroblast differentiation of lung fibroblasts during pulmonary fibrosis. Silibinin (SIL), a bioactive compound derived from Silybum marianum l., has been proven to suppress inflammatory responses in a bleomycin (BLM) mouse model, but the protective mechanisms and specific molecular target through which SIL acts in pulmonary fibrosis remain unclear. OBJECTIVES: This study aimed to identify the direct molecular target of SIL, and investigate the mechanisms by which SIL exerts its anti-fibrotic effect. METHODS: A mouse model of BLM-induced pulmonary fibrosis and a cellular model of TGF-β1-induced fibroblast activation were utilized to explore the mechanism by which SIL inhibits fibroblast functions. Limited proteolysis-mass spectrometry (LiP-MS) technology, molecular docking and surface plasmon resonance (SPR) were used to identify the molecular target of SIL. RESULTS: SIL treatment significantly attenuated BLM-induced pulmonary fibrosis in mice by suppressing both the proliferation and differentiation of lung fibroblasts. SIL also reduced BLM-induced ER stress and oxidative stress in mouse lung fibroblasts. In vitro, SIL markedly inhibited TGF-β1-induced fibroblast proliferation, myofibroblast differentiation, and extracellular matrix (ECM) deposition by attenuating ER stress and oxidative stress in primary normal human lung fibroblasts (NHLFs), IPF-derived lung fibroblasts (IPF-HLFs), and the MRC-5 cell line. Using an integrated approach combining LIP-MS, molecular docking, and SPR, we identified Annexin A6 (ANXA6) as the direct molecular target of SIL. ANXA6 knockdown in lung fibroblasts reduced TGF-β1-induced ROS accumulation, ER stress, and subsequent fibroblast activation, whereas ANXA6 overexpression exacerbated these effects. Mechanistically, SIL bound to ANXA6, leading to inactivation of the PI3K/AKT/mTOR signaling and thereby alleviating fibroblast activation. CONCLUSION: Our finding identifies ANXA6 as a promising therapeutic target for pulmonary fibrosis and proposes SIL as its natural inhibitor, thereby providing crucial mechanistic insights for developing ANXA6-targeted therapies against IPF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oxidative StressSilybinPulmonary FibrosisEndoplasmic Reticulum StressAnimalsFibroblastsBleomycinMiceTransforming Growth Factor beta1Cell ProliferationHumansCell DifferentiationLungMice, Inbred C57BLMaleMolecular Docking Simulation

Stichwörter der Autor:innen

ANXA6Endoplasmic reticulum stressFibroblast activationOxidative stressPulmonary fibrosisSilibinin

Substanzen

SilybinBleomycinTransforming Growth Factor beta1

Autor:innen und Institutionen

  • State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou…
  • Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.
  • Department of Transplantation, Department of Thoracic Surgery and Oncology, the First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease & National Clinical Research Center…

Förderung

  • National Natural Science Foundation of China
  • State Key Laboratory of Respiratory Disease
  • Natural Science Foundation of Henan Province

Zitieren

APA

Guan, R., Zhang, Y., Wang, Z., Huang, D., Bai, Y., Deng, M., Li, K., Hu, X., Huang, F., Dai, Y., Tian, F., Xu, Z., Yang, T., Peng, G., & Xu, X. (2026). Silibinin alleviates lung fibrosis by targeting Annexin A6 to suppress endoplasmic reticulum stress and oxidative stress. Phytomedicine. https://doi.org/10.1016/j.phymed.2026.158041

Vancouver

Guan R, Zhang Y, Wang Z, Huang D, Bai Y, Deng M, et al. Silibinin alleviates lung fibrosis by targeting Annexin A6 to suppress endoplasmic reticulum stress and oxidative stress. Phytomedicine. 2026. doi:10.1016/j.phymed.2026.158041

BibTeX
@article{Guan2026,
  author = {Guan, Ruijuan and Zhang, Yingli and Wang, Zhengyang and Huang, Danxia and Bai, Yakun and Deng, Meifang and Li, Kailin and Hu, Xiao and Huang, Fei and Dai, Ying and Tian, Fang and Xu, Zhiyuan and Yang, Tao and Peng, Guilin and Xu, Xin},
  title = {Silibinin alleviates lung fibrosis by targeting Annexin A6 to suppress endoplasmic reticulum stress and oxidative stress},
  journal = {Phytomedicine},
  year = {2026},
  doi = {10.1016/j.phymed.2026.158041}
}
Kostenlos starten →